Patients who switched from tirzepatide to orforglipron maintained a mean 74.7% of their body weight reduction from the SURMOUNT-5 trial compared with those in the placebo group, which maintained a mean 49.2% of their weight loss
The effects on the hypothalamic appetite signals, as depicted in Figure 8, offer a hypothesis on how liraglutide increases satiety and reduces feelings of hunger in patients
Today, its widely recognized for its powerful role in medical weight loss, helping patients manage appetite, reduce cravings, and achieve meaningful, sustainable results
Unfortunately, theres no magic pill to stop every kind of stomach upset
Previous bariatric surgery Patients with any history of gastric bypass, sleeve gastrectomy, or other bariatric procedures require lifelong b12 monitoring and supplementation